Jeff frequently represents corporations, directors, and officers in high-stakes litigation, investigations, and enforcement actions.
Jeff broadly focuses on complex commercial, life sciences, securities, and shareholder derivative litigation, as well as regulatory enforcement matters and board committee representations related to corporate governance.
With a distinct perspective attributable to having earned a medical degree, Jeff also specializes in advising clients in the pharmaceutical, biotech, and medical device industries on litigation, regulatory, and transaction-related matters.
Expertise
Experience
Representative matters
The special litigation committee of the board of directors of a pharmaceutical company in connection with shareholder derivative litigation.
The board of directors of an electric utility company in connection with shareholder derivative litigation.
A multinational financial institution in several mortgage-backed securities cases.
A committee of the board of directors of a pharmaceutical company in connection with shareholder derivative litigation.
A major health insurance provider in connection with a contract dispute.
Published Work
- Hoschander, Jeff (2023), Derivative Litigation and Pre-Suit Demands, Securities Litigation: A Practitioner’s Guide (Second Edition), (Practising Law Institute Treatise Chapter)
- Hoschander, Jeff, (2023) “Delaware Court of Chancery Rejects Stockholder Demand for Corporation to Supplement Its Section 220 Production with Searches and Production of Email”, The M&A Lawyer
- Hoschander, Jeff, (2023) “Delaware Court of Chancery Holds That Corwin Cleansing Does Not Apply to Claims for Injunctive Relief Related to Alleged Defensive Measures”, The M&A Lawyer
- Hoschander, Jeff, (2023) “Delaware Court of Chancery Dismisses Breach of Contract Claims Against Buyer, Finding Seller Retained Post-Closing Liability Related to Certain Product-Liability Litigations”, The M&A Lawyer
Awards
- “Future Star”, Benchmark Litigation, 2020-2023
Qualifications
Admissions
New York, 2007
Courts
United States Court of Appeals for the Second Circuit, 2018
United States Court of Appeals for the Third Circuit, 2023
United States Court of Appeals for the Ninth Circuit, 2019
United States District Court for the Southern District of New York, 2009
United States District Court for the Eastern District of New York, 2009
United States District Court for the Eastern District of Michigan, 2023
United States Court of Appeals for the Third Circuit, 2023
United States Court of Appeals for the Ninth Circuit, 2019
United States District Court for the Southern District of New York, 2009
United States District Court for the Eastern District of New York, 2009
United States District Court for the Eastern District of Michigan, 2023
Academic
B.A., Yeshiva University, 1999
J.D., New York University, 2006
M.D., Yale University, 2006
J.D., New York University, 2006
M.D., Yale University, 2006
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.